Recently, low DLG2 expression has been found in osteosarcoma (Shao et al. 2019), ovarian cancer (Zhuang et al. 2019) and neuroblastoma (Keane et al. 2020, 2021; Siaw et al. 2020). Here, DLG2 is linked to ovarian carcinoma.